ecancer

IKZF1 mutations associated with paediatric ALL

Dr Michelle Churchman - St. Jude Children's Research Hospital, Memphis, USA

5 Dec 2016

ALL: Combining paediatric-type therapy with minimal residual disease

Dr Alessandro Rambaldi - Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy

5 Dec 2016

Incidence and risk factors for central venous catheter related thrombosis in children

Dr Julie Jaffray - Children's Center for Cancer, Los Angeles, USA

3 Dec 2016

Remissions following anti-CD22 CAR therapy in children with relapsed ALL

Dr Terry Fry - National Cancer Institute, Bethesda, USA

3 Dec 2016

Therapeutic targeting of childhood medulloblastoma

Dr Sheila Singh - McMaster University, Hamilton, Canada

23 Nov 2016

Involving young people in cancer research

Lorna Fern - Teenage and Young Adult Clinical Studies Group, NCRI, UK

23 Nov 2016

Dabrafenib shows higher response and lower toxicity in paediatric brain cancer trial

Dr Mark Kieran - Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, USA

8 Oct 2016

A novel biomarker for paediatic tumours

Dr Kathleen Birley - UCL Institute of Child Health, London, UK

5 Oct 2016

Paediatric ALL with brain metastases

Dr Christina Halsey - University of Glasgow, Glasgow, UK

5 Oct 2016

miRNA screening for germ cell tumours

Dr Matthew Murray - University of Cambridge, Cambridge, UK

5 Oct 2016

ALK mutations in paediatric tumours

Dr Suzanne Turner - Cambridge University, Cambridge, UK

5 Oct 2016

Can we reduce exposure to risk factors associated with childhood leukaemia and other cancers?

Dr Mark Miller - UCSF, San Francisco, USA

29 Sep 2016

More from ecancer